Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 7 of 7 entries
Sorted by: Best Match Show Resources per page
An analysis of blood pressure screening of 21 112 participants in Armenia: May Measurement Month 2018.

European heart journal supplements : journal of the European Society of Cardiology

Zelveian P, Avagyan A, Minasyan A, Hayrumyan S, Gourgenyan S, Hakobyan Z, Kzhdryan H, Hakobjanyan V, Ustyan T, Gharibyan H, Melkonyan A, Aroyan S, Vatinyan S, Beaney T, Ster AC, Poulter NR.
PMID: 32884458
Eur Heart J Suppl. 2020 Aug;22:H14-H16. doi: 10.1093/eurheartj/suaa017. Epub 2020 Aug 28.

Elevated blood pressure (BP) is a growing burden worldwide and is the leading cause of mortality and disability-adjusted life years all over the world. May Measurement Month (MMM) is a global initiative aimed to raise awareness of high BP...

Cite
Zelveian P, Avagyan A, Minasyan A, et al. An analysis of blood pressure screening of 21 112 participants in Armenia: May Measurement Month 2018. Eur Heart J Suppl. 2020;22:H14-H16doi: 10.1093/eurheartj/suaa017.
Zelveian, P., Avagyan, A., Minasyan, A., Hayrumyan, S., Gourgenyan, S., Hakobyan, Z., Kzhdryan, H., Hakobjanyan, V., Ustyan, T., Gharibyan, H., Melkonyan, A., Aroyan, S., Vatinyan, S., Beaney, T., Ster, A. C., & Poulter, N. R. (2020). An analysis of blood pressure screening of 21 112 participants in Armenia: May Measurement Month 2018. European heart journal supplements : journal of the European Society of Cardiology, 22H14-H16. https://doi.org/10.1093/eurheartj/suaa017
Zelveian, Parounak, et al. "An analysis of blood pressure screening of 21 112 participants in Armenia: May Measurement Month 2018." European heart journal supplements : journal of the European Society of Cardiology vol. 22 (2020): H14-H16. doi: https://doi.org/10.1093/eurheartj/suaa017
Zelveian P, Avagyan A, Minasyan A, Hayrumyan S, Gourgenyan S, Hakobyan Z, Kzhdryan H, Hakobjanyan V, Ustyan T, Gharibyan H, Melkonyan A, Aroyan S, Vatinyan S, Beaney T, Ster AC, Poulter NR. An analysis of blood pressure screening of 21 112 participants in Armenia: May Measurement Month 2018. Eur Heart J Suppl. 2020 Aug;22:H14-H16. doi: 10.1093/eurheartj/suaa017. Epub 2020 Aug 28. PMID: 32884458; PMCID: PMC7455293.
Copy Download .nbib Format: NLM
Effects of dopamine, norepinephrine or phenylephrine on the prevention of hypotension in isoflurane-anesthetized cats administered vatinoxan or vatinoxan and dexmedetomidine.

Veterinary anaesthesia and analgesia

Kobluk K, Pypendop BH.
PMID: 34906421
Vet Anaesth Analg. 2021 Nov 12; doi: 10.1016/j.vaa.2021.11.001. Epub 2021 Nov 12.

OBJECTIVE: To determine the dose of phenylephrine, norepinephrine and dopamine necessary to maintain mean arterial pressure (MAP) within 70-80 mmHg during administration of isoflurane, isoflurane and vatinoxan and isoflurane, vatinoxan and dexmedetomidine at three plasma concentrations.STUDY DESIGN: Randomized crossover...

Cite
Kobluk K, Pypendop BH. Effects of dopamine, norepinephrine or phenylephrine on the prevention of hypotension in isoflurane-anesthetized cats administered vatinoxan or vatinoxan and dexmedetomidine. Vet Anaesth Analg. 2021;doi: 10.1016/j.vaa.2021.11.001.
Kobluk, K., & Pypendop, B. H. (2021). Effects of dopamine, norepinephrine or phenylephrine on the prevention of hypotension in isoflurane-anesthetized cats administered vatinoxan or vatinoxan and dexmedetomidine. Veterinary anaesthesia and analgesia, . https://doi.org/10.1016/j.vaa.2021.11.001
Kobluk, Kristi, and Pypendop, Bruno H. "Effects of dopamine, norepinephrine or phenylephrine on the prevention of hypotension in isoflurane-anesthetized cats administered vatinoxan or vatinoxan and dexmedetomidine." Veterinary anaesthesia and analgesia vol. (2021). doi: https://doi.org/10.1016/j.vaa.2021.11.001
Kobluk K, Pypendop BH. Effects of dopamine, norepinephrine or phenylephrine on the prevention of hypotension in isoflurane-anesthetized cats administered vatinoxan or vatinoxan and dexmedetomidine. Vet Anaesth Analg. 2021 Nov 12; doi: 10.1016/j.vaa.2021.11.001. Epub 2021 Nov 12. PMID: 34906421.
Copy Download .nbib Format: NLM
Cardiovascular effects of intravenous vatinoxan in wild boars (Sus scrofa) anaesthetised with intramuscular medetomidine-tiletamine-zolazepam.

The Veterinary record

Einwaller J, Meyer LCR, Auer U, Raekallio M, Nowack J, Haw A, Vetter S, Painer J, Stalder G.
PMID: 34472117
Vet Rec. 2021 Sep 01;e835. doi: 10.1002/vetr.835. Epub 2021 Sep 01.

BACKGROUND: The potent sedative medetomidine is a commonly used adjunct for the immobilisation of non-domestic mammals. However, its use is associated with pronounced cardiovascular side effects, such as bradycardia, vasoconstriction and decreased cardiac output. We investigated the effects of...

Cite
Einwaller J, Meyer LCR, Auer U, et al. Cardiovascular effects of intravenous vatinoxan in wild boars (Sus scrofa) anaesthetised with intramuscular medetomidine-tiletamine-zolazepam. Vet Rec. 2021;e835doi: 10.1002/vetr.835.
Einwaller, J., Meyer, L. C. R., Auer, U., Raekallio, M., Nowack, J., Haw, A., Vetter, S., Painer, J., & Stalder, G. (2021). Cardiovascular effects of intravenous vatinoxan in wild boars (Sus scrofa) anaesthetised with intramuscular medetomidine-tiletamine-zolazepam. The Veterinary record, e835. https://doi.org/10.1002/vetr.835
Einwaller, Joy, et al. "Cardiovascular effects of intravenous vatinoxan in wild boars (Sus scrofa) anaesthetised with intramuscular medetomidine-tiletamine-zolazepam." The Veterinary record vol. (2021): e835. doi: https://doi.org/10.1002/vetr.835
Einwaller J, Meyer LCR, Auer U, Raekallio M, Nowack J, Haw A, Vetter S, Painer J, Stalder G. Cardiovascular effects of intravenous vatinoxan in wild boars (Sus scrofa) anaesthetised with intramuscular medetomidine-tiletamine-zolazepam. Vet Rec. 2021 Sep 01;e835. doi: 10.1002/vetr.835. Epub 2021 Sep 01. PMID: 34472117.
Copy Download .nbib Format: NLM
May Measurement Month 2019: an analysis of blood pressure screening results from Armenia.

European heart journal supplements : journal of the European Society of Cardiology

Zelveian P, Hayrumyan S, Gourgenyan S, Hakobyan Z, Kzhdryan H, Avagyan A, Minasyan A, Gharibyan H, Ustyan T, Aroyan S, Vatinyan S, Beaney T, Clarke J, Poulter NR.
PMID: 34629989
Eur Heart J Suppl. 2021 May 20;23:B15-B17. doi: 10.1093/eurheartj/suab048. eCollection 2021 May.

Elevated blood pressure (BP) is an enormous public health problem and a growing burden worldwide and the biggest single risk factor for cardiovascular death. May Measurement Month (MMM) is a global initiative aimed to raise awareness of high BP...

Cite
Zelveian P, Hayrumyan S, Gourgenyan S, et al. May Measurement Month 2019: an analysis of blood pressure screening results from Armenia. Eur Heart J Suppl. 2021;23:B15-B17doi: 10.1093/eurheartj/suab048.
Zelveian, P., Hayrumyan, S., Gourgenyan, S., Hakobyan, Z., Kzhdryan, H., Avagyan, A., Minasyan, A., Gharibyan, H., Ustyan, T., Aroyan, S., Vatinyan, S., Beaney, T., Clarke, J., & Poulter, N. R. (2021). May Measurement Month 2019: an analysis of blood pressure screening results from Armenia. European heart journal supplements : journal of the European Society of Cardiology, 23B15-B17. https://doi.org/10.1093/eurheartj/suab048
Zelveian, Parounak, et al. "May Measurement Month 2019: an analysis of blood pressure screening results from Armenia." European heart journal supplements : journal of the European Society of Cardiology vol. 23 (2021): B15-B17. doi: https://doi.org/10.1093/eurheartj/suab048
Zelveian P, Hayrumyan S, Gourgenyan S, Hakobyan Z, Kzhdryan H, Avagyan A, Minasyan A, Gharibyan H, Ustyan T, Aroyan S, Vatinyan S, Beaney T, Clarke J, Poulter NR. May Measurement Month 2019: an analysis of blood pressure screening results from Armenia. Eur Heart J Suppl. 2021 May 20;23:B15-B17. doi: 10.1093/eurheartj/suab048. eCollection 2021 May. PMID: 34629989; PMCID: PMC8494059.
Copy Download .nbib Format: NLM
Effects of vatinoxan on xylazine-induced pulmonary alterations in sheep.

Journal of veterinary pharmacology and therapeutics

Adam M, Lindén J, Raekallio M, Meller A, Mannerström B, Abu-Shahba A, Seppänen-Kaijansinkko R, Salla K.
PMID: 34478172
J Vet Pharmacol Ther. 2022 Jan;45(1):117-125. doi: 10.1111/jvp.13013. Epub 2021 Sep 03.

It was hypothesized that premedication with vatinoxan, a peripheral α

Cite
Adam M, Lindén J, Raekallio M, et al. Effects of vatinoxan on xylazine-induced pulmonary alterations in sheep. J Vet Pharmacol Ther. 2021;45(1):117-125doi: 10.1111/jvp.13013.
Adam, M., Lindén, J., Raekallio, M., Meller, A., Mannerström, B., Abu-Shahba, A., Seppänen-Kaijansinkko, R., & Salla, K. (2022). Effects of vatinoxan on xylazine-induced pulmonary alterations in sheep. Journal of veterinary pharmacology and therapeutics, 45(1), 117-125. https://doi.org/10.1111/jvp.13013
Adam, Magdy, et al. "Effects of vatinoxan on xylazine-induced pulmonary alterations in sheep." Journal of veterinary pharmacology and therapeutics vol. 45,1 (2022): 117-125. doi: https://doi.org/10.1111/jvp.13013
Adam M, Lindén J, Raekallio M, Meller A, Mannerström B, Abu-Shahba A, Seppänen-Kaijansinkko R, Salla K. Effects of vatinoxan on xylazine-induced pulmonary alterations in sheep. J Vet Pharmacol Ther. 2022 Jan;45(1):117-125. doi: 10.1111/jvp.13013. Epub 2021 Sep 03. PMID: 34478172.
Copy Download .nbib Format: NLM
May Measurement Month 2017: an analysis of blood pressure screening results in Armenia-Europe.

European heart journal supplements : journal of the European Society of Cardiology

Zelveian P, Avagyan A, Minasyan A, Hakobyan Z, Ustyan T, Gharibyan H, Melkonyan A, Aroyan S, Vatinyan S, Gourgenyan S, Beaney T, Xia X, Poulter NR.
PMID: 31043865
Eur Heart J Suppl. 2019 Apr;21:D11-D13. doi: 10.1093/eurheartj/suz051. Epub 2019 Apr 24.

Elevated blood pressure (BP) is a growing burden worldwide, leading to over 10 million deaths each year. May Measurement Month (MMM) is a global initiative aimed at raising awareness of high BP and to act as a temporary solution...

Cite
Zelveian P, Avagyan A, Minasyan A, et al. May Measurement Month 2017: an analysis of blood pressure screening results in Armenia-Europe. Eur Heart J Suppl. 2019;21:D11-D13doi: 10.1093/eurheartj/suz051.
Zelveian, P., Avagyan, A., Minasyan, A., Hakobyan, Z., Ustyan, T., Gharibyan, H., Melkonyan, A., Aroyan, S., Vatinyan, S., Gourgenyan, S., Beaney, T., Xia, X., & Poulter, N. R. (2019). May Measurement Month 2017: an analysis of blood pressure screening results in Armenia-Europe. European heart journal supplements : journal of the European Society of Cardiology, 21D11-D13. https://doi.org/10.1093/eurheartj/suz051
Zelveian, Parounak, et al. "May Measurement Month 2017: an analysis of blood pressure screening results in Armenia-Europe." European heart journal supplements : journal of the European Society of Cardiology vol. 21 (2019): D11-D13. doi: https://doi.org/10.1093/eurheartj/suz051
Zelveian P, Avagyan A, Minasyan A, Hakobyan Z, Ustyan T, Gharibyan H, Melkonyan A, Aroyan S, Vatinyan S, Gourgenyan S, Beaney T, Xia X, Poulter NR. May Measurement Month 2017: an analysis of blood pressure screening results in Armenia-Europe. Eur Heart J Suppl. 2019 Apr;21:D11-D13. doi: 10.1093/eurheartj/suz051. Epub 2019 Apr 24. PMID: 31043865; PMCID: PMC6480932.
Copy Download .nbib Format: NLM
Effects of vatinoxan on xylazine-induced pulmonary alterations in sheep.

Journal of veterinary pharmacology and therapeutics

Adam M, Lindén J, Raekallio M, Meller A, Mannerström B, Abu-Shahba A, Seppänen-Kaijansinkko R, Salla K.
PMID: 34478172
J Vet Pharmacol Ther. 2021 Sep 03; doi: 10.1111/jvp.13013. Epub 2021 Sep 03.

It was hypothesized that premedication with vatinoxan, a peripheral α

Cite
Adam M, Lindén J, Raekallio M, et al. Effects of vatinoxan on xylazine-induced pulmonary alterations in sheep. J Vet Pharmacol Ther. 2021;doi: 10.1111/jvp.13013.
Adam, M., Lindén, J., Raekallio, M., Meller, A., Mannerström, B., Abu-Shahba, A., Seppänen-Kaijansinkko, R., & Salla, K. (2021). Effects of vatinoxan on xylazine-induced pulmonary alterations in sheep. Journal of veterinary pharmacology and therapeutics, . https://doi.org/10.1111/jvp.13013
Adam, Magdy, et al. "Effects of vatinoxan on xylazine-induced pulmonary alterations in sheep." Journal of veterinary pharmacology and therapeutics vol. (2021). doi: https://doi.org/10.1111/jvp.13013
Adam M, Lindén J, Raekallio M, Meller A, Mannerström B, Abu-Shahba A, Seppänen-Kaijansinkko R, Salla K. Effects of vatinoxan on xylazine-induced pulmonary alterations in sheep. J Vet Pharmacol Ther. 2021 Sep 03; doi: 10.1111/jvp.13013. Epub 2021 Sep 03. PMID: 34478172.
Copy Download .nbib Format: NLM
Showing 1 to 7 of 7 entries